Abstract
Hyperhomocysteinemia (HHcy): A condition that epidemiological studies have shown to be associated with increased risk of vascular disease and type 2 diabetes (T2D), arises from disrupted homocysteine (Hcy) and glucose metabolism. Our previous studies evaluating the regulation of Hcy metabolism from the molecular, cell, animal and population levels have demonstrated that utilization of Hcy by the trans-sulfuration and remethylation pathways is regulated by omega-3 polyunsaturated fatty acids (PUFA). This interaction was then identified as having protective effects on the cardiovascular system. Furthermore, observational studies we conducted found potential beneficial effects of omega-3 PUFA on insulin sensitivity and T2D.
To date, no literature reports have discussed the mechanism behind metabolism of omega-3 PUFA, Hcy and glucose from a nutriproteomic and nutrigenomic point of view. This review comprehensively summarizes the metabolism of omega-3 PUFA, Hcy and glucose; and their regulation by omega-3 PUFA on critical gene expression, a key enzyme activity involved in the Hcy metabolic and insulin signaling pathways.
In summary, high dietary omega-3 PUFA decreases blood Hcy and glucose concentrations. Omega-3 PUFA decreases the concentration of Hcy despite increasing MAT activity and up-regulating MAT mRNA expression through compensatory cystathionine-g-lyase mRNA expression, both of which are involved in Hcy metabolism. Omega-3 PUFA had a beneficial effect on insulin sensitivity and directly targeted insulin signaling pathway via increasing insulin receptor number, tyrosine phosphrylation of IRS-1, serine phosphorylation of Akt, gene expression of IRS-1, IRS-2 and GLUT-4 in different tissues. More research is warranted to explore the precise mechanism.
Keywords: Glucose, Hcy, nutrigenomics, nutriproteomics, ometa-3 PUFA.
Current Proteomics
Title:Nutriproteomics and Nutrigenomics: Exploring the Mechanism Behind omega-3 Polyunsaturated Fatty Acids, Homocysteine and Glucose Metabolism
Volume: 10 Issue: 1
Author(s): Tao Huang, Ju-Sheng Zheng, Nestor Mojica and Duo Li
Affiliation:
Keywords: Glucose, Hcy, nutrigenomics, nutriproteomics, ometa-3 PUFA.
Abstract: Hyperhomocysteinemia (HHcy): A condition that epidemiological studies have shown to be associated with increased risk of vascular disease and type 2 diabetes (T2D), arises from disrupted homocysteine (Hcy) and glucose metabolism. Our previous studies evaluating the regulation of Hcy metabolism from the molecular, cell, animal and population levels have demonstrated that utilization of Hcy by the trans-sulfuration and remethylation pathways is regulated by omega-3 polyunsaturated fatty acids (PUFA). This interaction was then identified as having protective effects on the cardiovascular system. Furthermore, observational studies we conducted found potential beneficial effects of omega-3 PUFA on insulin sensitivity and T2D.
To date, no literature reports have discussed the mechanism behind metabolism of omega-3 PUFA, Hcy and glucose from a nutriproteomic and nutrigenomic point of view. This review comprehensively summarizes the metabolism of omega-3 PUFA, Hcy and glucose; and their regulation by omega-3 PUFA on critical gene expression, a key enzyme activity involved in the Hcy metabolic and insulin signaling pathways.
In summary, high dietary omega-3 PUFA decreases blood Hcy and glucose concentrations. Omega-3 PUFA decreases the concentration of Hcy despite increasing MAT activity and up-regulating MAT mRNA expression through compensatory cystathionine-g-lyase mRNA expression, both of which are involved in Hcy metabolism. Omega-3 PUFA had a beneficial effect on insulin sensitivity and directly targeted insulin signaling pathway via increasing insulin receptor number, tyrosine phosphrylation of IRS-1, serine phosphorylation of Akt, gene expression of IRS-1, IRS-2 and GLUT-4 in different tissues. More research is warranted to explore the precise mechanism.
Export Options
About this article
Cite this article as:
Huang Tao, Zheng Ju-Sheng, Mojica Nestor and Li Duo, Nutriproteomics and Nutrigenomics: Exploring the Mechanism Behind omega-3 Polyunsaturated Fatty Acids, Homocysteine and Glucose Metabolism, Current Proteomics 2013; 10 (1) . https://dx.doi.org/10.2174/15701646112099990004
DOI https://dx.doi.org/10.2174/15701646112099990004 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Recent Patents on Anti-Cancer Drug Discovery Retracted: Potential Health Benefits of Broccoli- A Chemico-Biological Overview
Mini-Reviews in Medicinal Chemistry The Epidemiology and Health Effects of Tobacco Use
Current Pediatric Reviews Clinical Pharmacogenetics of Methotrexate
Current Drug Metabolism Association Between Adiposity Indices and Blood Pressure is Stronger in Sarcopenic Obese Women
Current Hypertension Reviews Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
Current Vascular Pharmacology Computational Biological Analysis Reveals a Role for Nitric Oxide Synthase and Adiponectin in the Pathobiology of Insulin Resistance Syndrome and Coronary Artery Disease
Current Nutrition & Food Science Influence of Impaired Liver Methionine Metabolism on the Development of Vascular Disease and Inflammation
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Role of Angiotensin Type 1 Receptor in Inflammation and Endothelial Dysfunction
Recent Patents on Cardiovascular Drug Discovery Macrocyclic Compounds: Emerging Opportunities for Current Drug Discovery
Current Pharmaceutical Design Circulating miRNAs in Successful and Unsuccessful Aging. A Mini-review
Current Pharmaceutical Design Platelets and Vascular Risk: An Option for Treatment
Current Pharmaceutical Design The Nitric Oxide Signaling Pathway in the Penis
Current Pharmaceutical Design Rheumatoid Arthritis: Conjugating Basics with Drug Delivery
Current Rheumatology Reviews Hormones and Sarcopenia
Current Pharmaceutical Design Pregnancy and Postpartum Influences on Rheumatoid Arthritis Activity:Natures Model to Investigate Systemic Biological Mechanisms in the Disease
Current Rheumatology Reviews Thioredoxin-1 is a Novel and Attractive Therapeutic Approach for Various Diseases Including Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets Proteomic Analysis of Plasma to Reveal the Impact of Short-Term Etanercept Therapy in Pediatric Patients with Enthesitis-Related Arthritis: A Case Report
Combinatorial Chemistry & High Throughput Screening Circadian Variation of Cardiovascular Events and Morning Blood Pressure Surge
Vascular Disease Prevention (Discontinued)